Scorpius Holdings, Inc. Files 8-K with Financials and Equity Sales
Ticker: SCPX · Form: 8-K · Filed: Jul 23, 2025 · CIK: 1476963
| Field | Detail |
|---|---|
| Company | Scorpius Holdings, Inc. (SCPX) |
| Form Type | 8-K |
| Filed Date | Jul 23, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, financial-obligation, equity-securities, financial-statements
Related Tickers: SCPX
TL;DR
SCPX filed an 8-K detailing new financial obligations, equity sales, and financials. Check it out.
AI Summary
On July 11, 2025, Scorpius Holdings, Inc. entered into a material definitive agreement related to a direct financial obligation. The company also reported on the unregistered sales of equity securities and filed financial statements and exhibits. Scorpius Holdings, Inc. was formerly known as NightHawk Biosciences, Inc. and HEAT BIOLOGICS, INC.
Why It Matters
This filing provides crucial updates on Scorpius Holdings' financial obligations, equity transactions, and overall financial health, which are important for investors to assess the company's current standing.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements, financial obligations, and unregistered equity sales, which can indicate significant corporate actions and potential financial risks.
Key Players & Entities
- Scorpius Holdings, Inc. (company) — Registrant
- July 11, 2025 (date) — Date of earliest event reported
- NightHawk Biosciences, Inc. (company) — Former company name
- HEAT BIOLOGICS, INC. (company) — Former company name
- 20250711 (date) — Conformed period of report
FAQ
What specific material definitive agreement did Scorpius Holdings, Inc. enter into?
The filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in the provided text.
What was the nature of the direct financial obligation or off-balance sheet arrangement?
The filing states that Scorpius Holdings, Inc. has a direct financial obligation or an obligation under an off-balance sheet arrangement, but the specifics are not detailed in the provided text.
When did Scorpius Holdings, Inc. previously change its name?
Scorpius Holdings, Inc. was formerly known as NightHawk Biosciences, Inc. as of May 2, 2022, and prior to that, as HEAT BIOLOGICS, INC. as of November 17, 2009.
What are the key items reported in this 8-K filing?
The key items reported are the entry into a material definitive agreement, creation of a direct financial obligation or off-balance sheet arrangement, unregistered sales of equity securities, and financial statements and exhibits.
What is the SIC code for Scorpius Holdings, Inc.?
The Standard Industrial Classification (SIC) code for Scorpius Holdings, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 23, 2025 regarding Scorpius Holdings, Inc. (SCPX).